How hydroquinone fades dark spots and how to use it safely

Hydroquinone is a topical medicine that lightens dark patches of skin by slowing down melanin production in pigment cells. It is one of the best-studied treatments for melasma, dark marks left after acne or inflammation, and sun spots, and it is normally used at 2% to 4% for a limited course under medical supervision [1][4].

Used well, it can make a real difference to stubborn pigmentation. Used badly (too strong, too long, or from an unregulated product), it can irritate the skin or, rarely, cause a blue-grey discoloration called exogenous ochronosis. This guide explains how it works, what the evidence shows, how a typical course is structured and why, in the EU, you will only find it as a medicine and never in a cosmetic cream.

Key takeaways

- Hydroquinone blocks tyrosinase, the enzyme melanocytes use to make melanin, so it fades pigment gradually over weeks [1][12].

- In trials, a triple combination of hydroquinone, tretinoin and a mild corticosteroid lightened melasma more than hydroquinone alone [2][3].

- Courses are limited: product information in Spain advises stopping if there is no improvement after 2 months and never using it for more than 6 months [12].

- EU cosmetics law prohibits hydroquinone in cosmetic products, apart from professional artificial nail systems [14][15].

- It is not recommended in pregnancy or while breastfeeding [11][12].

How hydroquinone works on pigment

Skin colour comes from melanin, made by melanocytes in the bottom layer of the epidermis. The key enzyme in that process is tyrosinase, which converts the amino acid tyrosine into melanin precursors [1].

Hydroquinone acts in two ways:

• It inhibits tyrosinase, so less new melanin is made [1][10].
• It affects the melanocyte itself, altering melanosomes (the small packets that carry pigment) and, at the cellular level, damaging melanocytes directly [12].

Because it only interferes with the formation of new melanin, results are not immediate. Existing pigment has to fade as skin cells turn over. The effect is also temporary: once treatment stops, melanin production resumes, which is why sun protection and a maintenance plan matter so much [12].

What the evidence shows

Hydroquinone has been used for hyperpigmentation for more than five decades and remains a reference treatment in reviews [1][7].

Melasma

A Cochrane review included 20 randomised trials with 2,125 participants. The authors judged study quality generally poor, but found that triple combination cream (hydroquinone, tretinoin and fluocinolone acetonide) lightened melasma more than hydroquinone alone (risk ratio 1.58) [2]. A later evidence review of 113 studies and 6,897 participants concluded that hydroquinone alone and triple combination cream are the most effective and best-studied treatments for melasma, while peels and lasers were equal or inferior to topicals with more adverse effects [4].

In two 8-week trials with 641 adults with moderate to severe melasma, 26.1% of people using the triple combination had complete clearing, compared with 4.6% on dual combinations, and more than 70% had at least a 75% reduction in pigmentation, compared with 30% [3]. Most side effects were mild redness, peeling, burning or stinging [3].

If you want the bigger picture on melasma triggers and the full range of options, see our article on melasma causes and treatment and the melasma treatment page.

Post-inflammatory hyperpigmentation

Dark marks after acne, eczema or minor injuries also respond. A review of acne-related marks describes 4% hydroquinone used twice daily for up to 6 months, with efficacy enhanced by a nightly retinoid, and notes that occasional irritation can be managed with a short break [5]. Spot treatment suits a few marks; wider "field" treatment suits many [5].

Sun spots (solar lentigines)

Hydroquinone is also used for sun spots and freckles [1][12]. In a randomised trial of 50 people with sun spots on the back of the hands, a 2-week course of triple combination cream before cryotherapy reduced the number of spots faster than sunscreen alone [6]. If you are not sure what kind of dark spot you have, our guide to dark spots on the face walks through the common causes.

Strengths and formulations compared

Option	Typical strength	Where the evidence points	Notes
Hydroquinone alone	2% to 4%	Effective for melasma, post-acne marks and sun spots [1][4]	2% is often well tolerated; higher strengths irritate more [1]
Triple combination (hydroquinone + tretinoin + mild corticosteroid)	4% hydroquinone, 0.05% tretinoin, 0.01% fluocinolone in trials	Most effective topical option for melasma in trials [2][3]	Corticosteroid on the face should not be used long term [5]
Azelaic acid	20%	More effective than 2% hydroquinone, with no significant difference versus 4% in melasma [2]	An alternative when hydroquinone is unsuitable or after a course
Oral tranexamic acid	Varies	Promising add-on for moderate to severe recurrent melasma [4]	Prescribed in person by a dermatologist; long-term data still limited [4]

For practical details on specific formulas, see our hydroquinone cream guide and our melasma combination formula guide.

How to use hydroquinone safely

The exact plan always comes from the prescriber, but authorised product information and the clinical literature agree on several principles [12][10]:

1. A skin test first. The product information describes testing a small amount on the inner forearm for at least a full day before the face; if strong irritation appears, it is not used [12].
2. A thin layer, only on the spots. It is applied to small pigmented areas, away from the eyes, lips and mucous membranes, and only on intact skin (never on broken, eczematous or sunburnt skin) [12].
3. A gradual start. Spanish product information describes once a day at night for 10 to 15 days, then more often if tolerated [12]. Your doctor sets the schedule and may keep it nightly.
4. Clean hands afterwards. Hydroquinone can leave reversible brown stains on the nails [12].
5. Daily sunscreen. Even small amounts of sun can restart melanin production; a high-protection sunscreen reapplied every 2 to 3 hours during exposure is recommended [12].
6. Not at the same time as peroxides. Used together with benzoyl peroxide or hydrogen peroxide, it can stain the skin temporarily [12].

How long a course lasts

Courses are deliberately limited. Product information in Spain recommends 60 to 90 days of treatment, stopping if there is no improvement after 2 months and never exceeding 6 months [12]. A dermatology review notes that the risk of ochronosis is low with concentrations of 5% or less used for a limited period with regular monitoring [10]. After a course, the doctor reassesses the skin before any further cycle and may suggest a different option to keep results, such as azelaic acid, which performed similarly to 4% hydroquinone in melasma trials [2], always with strict sun protection [12].

Fading after stopping can last 2 to 6 months, but darker lesions tend to repigment sooner, which is why melasma is best thought of as controlled rather than eliminated [12].

Side effects and risks

Most side effects are local and mild [2][3]:

• Irritant or allergic contact dermatitis: redness, itching, stinging or a rash. Allergic reactions are less common but mean stopping [1][12].
• Lighter patches (hypopigmentation): skin can lighten beyond the spot, one reason it is applied only to the pigmented area [1]. True loss of pigment (leukoderma) is very rare [12].
• Rebound darkening: irritation itself can trigger new post-inflammatory pigmentation [1].
• Nail staining: brown, reversible [1][12].

Exogenous ochronosis

This is the complication that worries people most. It shows up as blue-black or grey-blue lace-like patches on the face [9]. A systematic review of 126 reported cases found it was most often linked with concentrations above 4% or unknown concentrations, with a median use of 5 years; only four cases involved courses of 3 months or less [9]. A US review counted 22 cases in more than 50 years across over 10,000 supervised exposures [8]. Reviews also report no documented case of skin or internal cancer linked to medical hydroquinone use over 40 to 50 years [7].

The message is not that hydroquinone is dangerous, but that dose, duration and supervision matter.

Why hydroquinone is a medicine in the EU

Under the EU Cosmetics Regulation, hydroquinone is listed in Annex II (substances prohibited in cosmetic products), with the only exception being Annex III entry 14: artificial nail systems for professional use, at a maximum of 0.02% after mixing [14][15]. That means any "lightening cream" sold as a cosmetic in the EU must not contain it.

As a medicine, it is regulated by national agencies. In Spain, the hydroquinone 4% creams and gels listed in the AEMPS medicines database are classed as prescription-only, while a few 2% preparations are authorised medicines sold in pharmacies [13].

A warning about unregulated lightening products

Skin-lightening products bought online or from informal markets can contain undeclared hydroquinone at high strengths or even mercury. The WHO describes mercury-containing lightening products as hazardous to health and banned in many countries, yet still available through internet sales [16]. Mercury can be toxic to the kidneys, skin, nervous system and other organs [17]. If a product has no clear ingredient list, no authorisation and promises fast whitening, avoid it.

Pregnancy and breastfeeding

Hydroquinone has relatively high systemic absorption compared with most topical skin products, so it is generally avoided during pregnancy [11][1]. Spanish product information states that safety in pregnancy and breastfeeding has not been established and advises against its use [12]. Melasma often appears or worsens in pregnancy; in that situation, gentle care and strict sun protection come first, and any treatment choice should be discussed with your doctor.

When to see a doctor

Get medical advice, and in some cases an in-person dermatology visit, if:

• A dark spot is new, changing, growing, irregular in colour or border, itchy or bleeding. Any of these needs an in-person skin check to rule out skin cancer.
• You notice blue-grey or blue-black patches where you have used a lightening product.
• Your skin becomes very red, swollen, blistered or painful after applying hydroquinone.
• There is no improvement after 2 months of a course [12].
• You are pregnant, trying to conceive or breastfeeding.
• Pigmentation is widespread, deep (dermal) or not responding to topicals. A dermatologist may discuss in-person options such as peels, lasers or oral tranexamic acid [4].

A doctor reviews your skin, history and medicines and decides whether hydroquinone, a combination formula or an alternative is appropriate for you. Hi Doctor is an online consultation service with doctors licensed in Spain; skin treatments offered are topical only, and a doctor replies in under 2 hours on average. You can see how the process works on our how it works page.

Sources

1. Fabian IM, Sinnathamby ES, Flanagan CJ, et al. Topical Hydroquinone for Hyperpigmentation: A Narrative Review. Cureus. 2023;15(11):e48840. doi:10.7759/cureus.48840. https://pubmed.ncbi.nlm.nih.gov/38106810/
2. Rajaratnam R, Halpern J, Salim A, Emmett C. Interventions for melasma. Cochrane Database Syst Rev. 2010;(7):CD003583. doi:10.1002/14651858.CD003583.pub2. https://pubmed.ncbi.nlm.nih.gov/20614435/
3. Taylor SC, Torok H, Jones T, et al. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. Cutis. 2003;72(1):67-72. https://pubmed.ncbi.nlm.nih.gov/12889718/
4. McKesey J, Tovar-Garza A, Pandya AG. Melasma Treatment: An Evidence-Based Review. Am J Clin Dermatol. 2020;21(2):173-225. doi:10.1007/s40257-019-00488-w. https://pubmed.ncbi.nlm.nih.gov/31802394/
5. Chandra M, Levitt J, Pensabene CA. Hydroquinone therapy for post-inflammatory hyperpigmentation secondary to acne: not just prescribable by dermatologists. Acta Derm Venereol. 2012;92(3):232-5. doi:10.2340/00015555-1225. https://pubmed.ncbi.nlm.nih.gov/22002814/
6. Hexsel D, Hexsel C, Porto MD, Siega C. Triple combination as adjuvant to cryotherapy in the treatment of solar lentigines: investigator-blinded, randomized clinical trial. J Eur Acad Dermatol Venereol. 2015;29(1):128-33. doi:10.1111/jdv.12484. https://pubmed.ncbi.nlm.nih.gov/24684165/
7. Nordlund JJ, Grimes PE, Ortonne JP. The safety of hydroquinone. J Eur Acad Dermatol Venereol. 2006;20(7):781-7. doi:10.1111/j.1468-3083.2006.01670.x. https://pubmed.ncbi.nlm.nih.gov/16898897/
8. Levitt J. The safety of hydroquinone: a dermatologist's response to the 2006 Federal Register. J Am Acad Dermatol. 2007;57(5):854-72. doi:10.1016/j.jaad.2007.02.020. https://pubmed.ncbi.nlm.nih.gov/17467115/
9. Ishack S, Lipner SR. Exogenous ochronosis associated with hydroquinone: a systematic review. Int J Dermatol. 2022;61(6):675-684. doi:10.1111/ijd.15878. https://pubmed.ncbi.nlm.nih.gov/34486734/
10. Searle T, Al-Niaimi F, Ali FR. Hydroquinone: myths and reality. Clin Exp Dermatol. 2021;46(4):636-640. doi:10.1111/ced.14480. https://pubmed.ncbi.nlm.nih.gov/33159818/
11. Bozzo P, Chua-Gocheco A, Einarson A. Safety of skin care products during pregnancy. Can Fam Physician. 2011;57(6):665-7. https://pubmed.ncbi.nlm.nih.gov/21673209/
12. AEMPS, Centro de Información de Medicamentos (CIMA). Ficha técnica: hidroquinona 40 mg/g crema (registration no. 81390). https://cima.aemps.es/cima/dochtml/ft/81390/FT_81390.html
13. AEMPS, CIMA. Authorised medicines containing hidroquinona, with prescription status (database query). https://cima.aemps.es/cima/rest/medicamentos?practiv1=hidroquinona
14. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (Annexes II and III). https://eur-lex.europa.eu/eli/reg/2009/1223/oj
15. Commission Regulation (EU) No 344/2013 of 4 April 2013 amending Annexes II, III, V and VI to Regulation (EC) No 1223/2009 on cosmetic products (Annex II entry 1339; Annex III entry 14). https://eur-lex.europa.eu/eli/reg/2013/344/oj
16. World Health Organization. Mercury in skin lightening products. WHO/CED/PHE/EPE/19.13. Geneva: WHO; 2019. https://www.who.int/publications/i/item/WHO-CED-PHE-EPE-19.13
17. World Health Organization. Mercury and health (fact sheet). 2024. https://www.who.int/news-room/fact-sheets/detail/mercury-and-health